CAPECITABINE ACCORD 500 MG
Capécitabine
Public price
1.947,00 MAD
Active substance
Capécitabine
Laboratory
VIATRIS PHARMACEUTICALS
What is this medicine?
Capecitabine is a nucleoside metabolic inhibitor used in the treatment of various malignancies.
Verified summary
Capécitabine, Boite de 120, 500 MG, Comprimé pelliculé
Common uses
Treatment of colorectal cancer (including Stage III colon cancer, locally advanced rectal cancer, and unresectable or metastatic colorectal cancer), advanced or metastatic breast cancer, unresectable or metastatic gastric, esophageal, or gastroesophageal junction cancer, and pancreatic adenocarcinoma.
Class
nucleoside metabolic inhibitor
Laboratory
VIATRIS PHARMACEUTICALS
Strength
500 MG
Form
Boite de 120
Presentation
Comprimé pelliculé
Therapeutic class
Antinéoplasique, antimétabolite (antagoniste de la pyrimidine)
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-02: 1.947,00 MAD
Available presentations and strengths
Medicines with the same active substance
XELODA
150 MG · 1 BOITE 60 COMPRIME
0,00 MAD
XELABINE
500 MG · BOITE DE 120
1,78 MAD
CAPECITABINE MYLAN
500 MG · BOITE DE 120
1,95 MAD
DIROGIT
500 MG · BOITE DE 120
1,95 MAD
EPITEA
500 MG · BOITE DE 120
1,95 MAD
XEPINE
500 MG · BOITE DE 120
1,95 MAD
XELODA
500 MG · BOITE DE 120
1,98 MAD
CAPECITABINE MYLAN 500 MG
500 MG · Boite de 20
1.947,00 MAD
CAPECITABINE MYLAN 500 MG
500 MG · Boite de 120
1.947,00 MAD
DIROGITE 500 MG
500 MG · Boite de 120
1.947,00 MAD
XEPINE 500 MG
500 MG · Boite de 120
1.947,00 MAD
XELODA 500 MG
500 MG · Boîte de 120
1.983,00 MAD